FONAR (FONR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Executive summary
A special meeting is scheduled for May 28, 2026, for shareholders to vote on a proposed merger where the company will be acquired and taken private by an entity controlled by its CEO and other insiders, at $19.00 per share for Common and Class B stock, $6.34 for Class C, and $10.50 for Class A Non-voting Preferred Stock, representing significant premiums to recent trading prices.
The merger is structured as a “going private” transaction, with the company becoming a wholly owned subsidiary of the acquiring entity, and its shares delisted from Nasdaq.
The transaction is subject to approval by both a majority of all voting shares and a majority of votes cast by disinterested shareholders, with additional litigation requiring a potential supermajority vote under Delaware law.
A Special Committee of independent directors, advised by outside legal and financial advisors, negotiated the terms and unanimously recommended the merger as fair and in the best interests of unaffiliated shareholders.
An independent fairness opinion from Marshall & Stevens concluded the merger consideration is fair from a financial point of view to public shareholders.
Voting matters and shareholder proposals
Shareholders are being asked to vote on the merger proposal and, if necessary, a proposal to adjourn the meeting to solicit additional proxies.
Approval requires both a majority of all voting shares and a majority of votes cast by disinterested shareholders, with a pending lawsuit seeking to require a two-thirds supermajority of unaffiliated shares.
Dissenting shareholders have appraisal rights under Delaware law to seek a judicial determination of fair value.
Board of directors and corporate governance
The Special Committee consisted of two independent, disinterested directors who led negotiations and were compensated with fixed fees not contingent on the merger outcome.
The board’s recommendation was made after full disclosure of interested directors’ stakes, with those directors recusing themselves from the vote.
After the merger, the board and management will be replaced by the acquirer’s appointees, with the CEO remaining in control.
Latest events from FONAR
- Independent directors secured a premium cash buyout in a going-private merger led by insiders.FONR
Proxy filing23 Mar 2026 - Independent directors secured a cash buyout at a premium, pending key stockholder approvals.FONR
Proxy Filing26 Feb 2026 - Six-month net income fell 16%, but quarterly net income rose 15%; merger at $19/share signed.FONR
Q2 202617 Feb 2026 - Definitive merger agreement signed for $19.00/share; quarterly net income up 15% year-over-year.FONR
Proxy Filing17 Feb 2026 - Management-led buyout at $19/share offers 31.5% premium, pending shareholder approval.FONR
Proxy Filing30 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditors amid continued growth and strong liquidity.FONR
Proxy Filing2 Dec 2025 - Revenue up 4% to $26M, but net income down 33% as costs rise and uncertainty persists.FONR
Q1 202614 Nov 2025 - Revenue up 1%, net income down 24%, with record scan volumes and expansion plans.FONR
Q4 202525 Sep 2025 - Net income rose 16% on record scan volumes and continued expansion of MRI centers.FONR
Q4 202413 Jun 2025